100
Participants
Start Date
February 22, 2024
Primary Completion Date
February 28, 2027
Study Completion Date
February 28, 2029
YL201 for Injection
Patients will be treated with YL201 intravenous (IV) infusion once every 3 weeks on Day 1 or twice every 3 weeks on Day 1 and Day 8 during a 3-week (21-day) cycle.
NOT_YET_RECRUITING
Sun Yat-Sen University Cancer Center, Guangzhou
NOT_YET_RECRUITING
Harbin Medical University Cancer Hospital, Harbin
NOT_YET_RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
NOT_YET_RECRUITING
Union Hospital of Huazhong University of Science and Technology Tongji Medical College, Wuhan
NOT_YET_RECRUITING
Liaoning Cancer Hospital, Shenyang
NOT_YET_RECRUITING
The First Affiliated Hospital of China Medical University, Shenyang
NOT_YET_RECRUITING
Shandong Tumor Hospital, Jinan
NOT_YET_RECRUITING
Zhongshan Hospital of Fudan University, Shanghai
NOT_YET_RECRUITING
Sichuan Provincial People's Hospital, Chengdu
NOT_YET_RECRUITING
West China Hospital of Sichuan University, Chengdu
NOT_YET_RECRUITING
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
NOT_YET_RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
NOT_YET_RECRUITING
Anhui Provincial Hospital, Hefei
NOT_YET_RECRUITING
The Second Affiliated Hospital of Anhui Medical University, Hefei
NOT_YET_RECRUITING
Peking University First Hospital, Beijing
NOT_YET_RECRUITING
Peking University Third Hospital, Beijing
NOT_YET_RECRUITING
Hunan Cancer Hospital, Hunan
NOT_YET_RECRUITING
Chongqing University Cancer Hospital, Chongqing
NOT_YET_RECRUITING
Nanjing Drum Tower hospital, Nanjing
NOT_YET_RECRUITING
Nantong Tumor Hospital, Nantong
NOT_YET_RECRUITING
The Second Hospital of Tianjin Medical University, Tianjin
RECRUITING
Ningbo Yinzhou No.2 Hospital, Ningbo
NOT_YET_RECRUITING
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
MediLink Therapeutics (Suzhou) Co., Ltd.
INDUSTRY